Diagnostic yield of bowel related abnormalities in multi-detector CT (MDCT) staging scans with

Priyashini Parag


CT scan technology has evolved exponentially in the last decade; particularly with the advent of multidetector CT. However, some protocols such as routine administration of positive oral contrast for bowel opacification in oncological staging CT scans have not been updated to keep pace with technological advances. This is a retrospective review of staging CT scan reports to determine the yield of bowel abnormalities on CT with routine use of positive oral contrast and to determine if they had any impact on management. If very few bowel abnormalities are detected and if those identified have little effect on management then the postive oral contrast used will be considered to have added little value to the radiologist report and its use will be obviated for MDCT.